Lazard Asset Management »

Xenon Pharmaceuticals shares owned by Lazard Asset Management

Quarter-by-quarter ownership of Xenon Pharmaceuticals (XENE) shares owned by Lazard Asset Management from 13F filings

Historical chart of Lazard Asset Management investment in Xenon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xenon Pharmaceuticals held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xenon Pharmaceuticals by Lazard Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.5M 79k 44.82
2020-09-30 $7.0k 705 9.93

More positions owned by Lazard Asset Management

Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
American Tower Reit (AMT)
Crown Castle Intl (CCI)
Exelon Corporation (EXC)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Alphabet Cap Stk Cl C (GOOG)
Canadian Natl Ry (CNI)
Ferrovial Se Ord Shs (FER)
Broadcom (AVGO)
Visa Com Cl A (V)
CSX Corporation (CSX)

View all positions for Lazard Asset Management

Top funds holding Xenon Pharmaceuticals

FMR
venBio Select Advisor
BlackRock
Driehaus Capital Management
Henderson Group
Wellington Management Company
Capital Research and Management Company - Division 3
Polar Capital Holdings
Braidwell
Commodore Capital
Alliancebernstein
State Street Corporation
Millennium Management
Jpmorgan Chase & Co
Jennison Associates

View all funds holding Xenon Pharmaceuticals